DM

Deidra Celeste Marcelle

Global Marketing Manager, Oncology at Pfizer

Deidra Celeste Marcelle, Healthcare MBA, is a seasoned professional in the pharmaceutical and healthcare industry, currently serving as Global Marketing Manager in Oncology at Pfizer since September 2020, where remarkable achievements include leading multiple national initiatives and earning ten national awards within the first ten months of employment. Deidra's extensive career spans over 25 years, with roles at organizations such as Global Blood Therapeutics (now Pfizer), University of Alabama at Birmingham, Iroko Pharmaceuticals, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, and Merck, showcasing a strong background in sales, marketing, and leadership. Notable accolades include the Pfizer Premier Club Award, the Tyrone Hill Peer-Voted Award, and consistent recognition for exceeding sales goals across various therapeutic areas. Academically, Deidra holds an MBA with a healthcare specialization from the University of Miami and a Bachelor of Applied Science from Southern University and A&M College.

Location

New York, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Pfizer

605 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.